Bio-Rad Laboratories SARS-CoV-2 Variant RT-PCR Assays

Friday, 23 April, 2021 | Supplied by: Bio-Rad Laboratories Pty Ltd


Bio-Rad Laboratories has launched its SARS-CoV-2 Variant RT-PCR Assays for research use only (RUO). The assays can detect SARS-CoV-2 (the virus associated with COVID-19) variants of concern, including P.1, B.1.351 and B.1.1.7, by distinguishing specific mutations in SARS-CoV-2 using reverse transcription PCR (RT-PCR), often prior to a next-generation sequencing (NGS) workflow for confirmation.

With the emergence of several SARS-CoV-2 variants of concern, public health researchers are looking for a quicker way to track the spread of these variants in a population. Laboratories that use NGS to track COVID-19 variants can detect these mutations quickly with Bio-Rad’s RT-PCR assays to rapidly prioritise which samples to submit for NGS. The assays join the company’s offering of research and testing products that are helping in the fight against COVID-19.

Online: www.bio-rad.com
Phone: 02 9914 2800
Related Products

Waters BD FACSDiscover A7 Cell Analyzer

The BD FACSDiscover A7 Cell Analyzer combines high spectral resolution and sensitivity with...

Lumiprobe CytoTracer fluorescent cell dyes

The dyes rapidly penetrate cells, form intracellular membrane-impermeable products, and deliver...

Navinci Diagnostics Naveni CD8/MHC-I Atto647N proximity ligation assay (PLA) kit

The Naveni CD8/MHC-I Atto647N is an in situ proximity ligation assay kit for the detection of the...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd